Seborrheic dermatitis-like eruption in patients taking isotretinoin therapy for acne: Retrospective study of five patients

American Journal of Clinical Dermatology

Volumn 9, Issue 4, 2008, Pages 255-261

  Barzila, Aviv ^a,b   David, Michael ^b,c   Trau, Henri ^a,b   Hodak, Emmilia ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Acne, treatment; Isotretinoin, adverse reactions; Seborrhoeic dermatitis

Indexed keywords

DAKTACORT; DERMACOMBIN; DERMATOLOGICAL AGENT; FLUOCINOLONE ACETONIDE; ISOTRETINOIN; KETOCONAZOLE; THREOLONE;

ACINETOBACTER; ACNE; ACNE VULGARIS; ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FACE RASH; FEMALE; HUMAN; LABORATORY TEST; MALE; NONHUMAN; PITYROSPORUM OVALE; PRIORITY JOURNAL; SEBORRHEIC DERMATITIS; STAPHYLOCOCCUS;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; FACIAL DERMATOSES; FEMALE; HUMANS; ISOTRETINOIN; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45949101319     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200809040-00005     Document Type: Article

References (27)

1. Meigel WM. How safe is oral isotretinoin? Dermatology 1997; 195 Suppl. 1: 22-8
2. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45: s150-7
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (2): 239-45
4. Connor MJ. Mechanisms of retinoid action on the skin. In: Lowe NJ, Marks R, editors. Retinoids: a clinician's guide. London: Martin Dunitz, 1998: 1-7
5. Sidell N, Connor MJ, Lowe NJ, et al. Effect of a systemic retinoid on immune responses to specific protein antigens in humans. J Invest Dermatol 1990; 95: 597-602
6. Adelman DC, Yen TY, Cumberland WG, et al. 13-cis retinoic acid enhances in vivo B-lymphocyte differentiation in patients with common variable immuno-deficiency. J Allergy Clin Immunol 1991; 88 (5): 705-12
7. McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001; 45: s188-94
8. Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf 2004; 3: 119-29
9. Plewig G, Jansen T. Seborrheic dermatitis. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999: 1482-9
10. Orfanos CE, Zouboulis ChC. Oral retinoids in the treatment of seborrhea and acne. Dermatology 1998; 196: 140-7
11. Tagami H, Tadaki T, Obata M, et al. Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea-pigs and humans: comparison with topical retinoic acid treatment. Br J Dermatol 1992; 127 (5): 470-5
12. Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990; 122 (1): 71-6
13. King K, Jones DH, Daltrey DC, et al. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982; 107: 583-90
14. Leyden JJ, McGinley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 1986; 86: 390-3
15. Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol 1987; 123 (5): 606-8
16. Williams RE, Doherty VR, Perkins W, et al. Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 1992 Apr; 126: 362-6
17. Coates P, Vyakrnam S, Ravenscroft JC, et al. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol 2005; 153: 1126-36
18. Weissmann A, Wagner A, Plewig G. Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis retinoic acid. Arch Dermatol Res 1981; 270: 179-83
19. Graham 2nd ML, Corey R, Califf R, et al. Isotretinoin and Staphylococcus aureus infection: a possible association. Arch Dermatol 1986; 122: 815-7
20. Boffa MJ, Dave VK. Facial cellulitis during oral isotretinoin treatment for acne. J Am Acad Dermatol 1994; 31: 800-2
21. Flemetakis AC, Tsambaos DG. Effects of synthetic retinoids on the growth of bacteria and their susceptibility to antibiotics. J Chemother 1989; 1: 374-6
22. Homel L, Geiger JM, Harms M, et al. Sebum excretion rate in subjects treated with oral all trans retinoic acid. Dermatology 1996; 193: 127-30
23. Penneys NS, Hernandez D. A sticky problem with etretinate [letter]. N Engl J Med 1991; 325: 521
24. Penneys NS, Taylor R, Hernandez D. Etretinate increases carcinoembryonic antigen in palmar scrapings. J Am Acad Dermatol 1992; 26: 940-2
25. Higgins EM, Pembroke AC. Sticky palms: an unusual side-effect of etretinate therapy. Clin Exp Dermatol 1993; 18: 389-92
26. Lockridge J, Ramos-Caro FA, Holloway K, et al. Tretinoin-induced sticky skin: a case report and review of the literature. Cutis 1999; 63: 142-4
27. Wantzin GL, Thomsen K. A new cutaneous side effect of isotretinoin [letter]. J Am Acad Dermatol 1985; 13 (4): 665